Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;97(11):4130-8.
doi: 10.1210/jc.2012-2285. Epub 2012 Aug 29.

Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity

Nikki C Bush  1 , Rita Basu, Robert A Rizza, K Sreekumaran Nair, Sundeep Khosla, Michael D Jensen
Affiliations

Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity

Nikki C Bush et al. J Clin Endocrinol Metab. 2012 Nov.

Abstract

Context: A central/visceral fat distribution and excess free fatty acid (FFA) availability are associated with dyslipidemia and insulin resistance. However, these two characteristics often coexist, making it difficult to detect the independent contributions of each. Whether FFA suppression is more closely linked to metabolic abnormalities is not clear.

Objective: The aim of the study was to examine the relationship between FFA suppression, body fat distribution, and fitness as contributors toward insulin resistance and hypertriglyceridemia.

Design: We measured systemic palmitate turnover using an iv infusion of [9,10-(3)H]palmitate; upper body sc adipose tissue (UBSQ) and visceral adipose tissue (VAT) with dual-energy x-ray absorptiometry and a single-slice abdominal computed tomography scan; fitness with a graded exercise treadmill test; and insulin sensitivity with both the iv glucose tolerance test (IVGTT) (SI(IVGTT)) and mixed meal tolerance test (SI(Meal)).

Setting: The study was conducted at a General Clinical Research Center.

Participants: Baseline data were obtained from 140 elderly adults (age, 60-88 yr; 83 males) and 60 young adults (age, 18-31 yr; 31 males) who participated in a previously published trial assessing the effects of 2-yr supplementation of dehydroepiandrosterone or testosterone on body composition, glucose metabolism, and bone density.

Interventions: There were no interventions.

Main outcome measures: We measured fasting plasma triglyceride (TG) concentrations, SI(IVGTT), and SI(Meal).

Results: Using multivariate regression analysis, the strongest combined predictors of TG concentrations were VAT, postmeal nadir FFA concentrations, sex, and age. The best predictors of SI(IVGTT) were IVGTT nadir palmitate concentration, VAT, UBSQ fat, fitness, and age, whereas the best predictors of SI(Meal) were meal nadir palmitate concentration, UBSQ fat, fitness, and sex.

Conclusions: FFA suppression is associated with both fasting TG concentrations and insulin sensitivity, independent of measures of adiposity.

Trial registration: ClinicalTrials.gov NCT00254371.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Top, Plasma palmitate concentrations during a MMTT (left) and IVGTT (right). Bottom, Plasma insulin concentrations during a MMTT (left) and IVGTT (right) in elderly males (●), elderly females (■), young males (○), and young females (□).
Fig. 2.
Fig. 2.
Independent associations of nadir palmitate concentrations during a MMTT (left) and IVGTT (right) with fasting plasma TG concentrations adjusted for age group, sex, and VAT. Partial R, 0.34 (MMTT) and 0.45 (IVGTT); P < 0.001 for both.
Fig. 3.
Fig. 3.
Independent associations of nadir palmitate concentration with insulin sensitivity determined from a MMTT (left) adjusted for UBSQ, VO2 max, and sex (partial R, −0.31; P < 0.001) and from an IVGTT (right) adjusted for VAT and UBSQ, VO2 max, and age group (partial R, −0.31; P < 0.001).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB, Sr, O'Donnell CJ. 2007. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48 - PubMed
    1. Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV. 1970. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49:2017–2035 - PMC - PubMed
    1. Kissebah AH, Adams PW, Wynn V. 1974. Plasma free fatty acid and triglyceride transport kinetics in man. Clin Sci Mol Med 47:259–278 - PubMed
    1. Nielsen S, Guo Z, Albu JB, Klein S, O'Brien PC, Jensen MD. 2003. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 111:981–988 - PMC - PubMed
    1. Spitzer JJ, Gold M. 1964. Free fatty acid metabolism by skeletal muscle. Am J Physiol 206:159–164 - PubMed

Publication types

MeSH terms

Associated data